In the face of current geopolitical developments and recent global upheavals, Europe is under pressure to reassert its position in access to pharmaceutical innovation. The United States is calling clearly for Europe to make an adequate – and therefore greater – contribution. The panel discussion examines this demand from multiple angles: industry, policy and patient advocacy will all have their say, bringing together voices from the US, Europe and Austria.